Skip to Content
DAEWOONG PHARMACEUTICAL CO.LTD.
View All Menu
KR
EN
About Daewoong
About Daewoong
Our Purpose
CEO Message
Affiliates
Global Network
Company Culture
History
Ethics
Compliance Program
CEO Message
CP Rating
CP Activities
Contact Us
R&D
R&D Centers
R&D Projects
Achievements
Research Result
Platform Technology
Manufacturing
Capabilities
Plants
Smart Factory
FDF CDMO
Product
Biologics
Chemicals
Newsroom
Press Release
PR Videos
Investors
Overview
Corporate Governance
Overview
Board of Directors
Stockholder Info
Stockholder's meeting
Annual Reports
Balance Sheet
Income Statement
Credit Rating
Stock Info
Stock Info
Stock Status
IR
Events & Presentations
Earnings announcement
FAQ
Careers
Close All Menu
Smart Factory
Increased production efficiency through process automation
Osong, South Korea
Oral Solid
Features
Manage production to warehouse through automated IT systems (QMS,LIMS,EMS)
Dedicated facility for mass production of oral solid
Capacity: 20Billion Tablets / Year
Facilities
Vertical Transfer System (VTS) Enclosed system to prevent cross-contamination, influx of any foreign materials, or tablet breakage
Vertical Transportation System (VTS)
Facilities for Tableting Multi-layered tablet machine, Tab-in-Tab machine, IR tablet machine
Depot Injection
Features
Equipped with Qualified Injection manufacturing facility
First in Korea to equip Dual Chamber Syringe (DCS) charging line
Capacity: 0.6Billion Vials / Year
Facilities
Equipped with facilities equivalent to original’s manufacturing scale, which prevents quality variance occurring from facility difference
Facilities serving wide manufacturing coverage:
Spray Dryer: New Spray-drying machine (CIP/SIP/aseptic process)
Homo mixer: Core manufacturing facility for Emulsion method
DCS filling machine: Custom-built facility
Isolator: Equipped with enclosed isolators for high potent API